Global Geographic Atrophy Market Trends and Growth Analysis 2025–2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

By How Much Is The Geographic Atrophy Market Expected To Expand Between 2025 And 2029?

The geographic atrophy market has expanded rapidly in recent years. Its value is expected to rise from $1.86 billion in 2024 to $2.11 billion in 2025, with a compound annual growth rate (CAGR) of 13.7%. This historical growth can be attributed to an expanding geriatric population, increasing demand for effective treatment solutions, a rise in the prevalence of geographic atrophy, enhanced health awareness, and an uptick in the incidence of retinal diseases.

The geographic atrophy market is anticipated to experience substantial expansion in the coming years, with projections indicating it will reach $3.47 billion by 2029, achieving a compound annual growth rate (CAGR) of 13.2%. This expected growth during the forecast period is primarily driven by an increased emphasis on research and development, a rise in R&D investments, the growing utilization of smartphones, increasing expenditure within the healthcare sector, and heightened investment in clinical trials. Noteworthy trends anticipated in this period include breakthroughs in gene therapy, advancements in healthcare technology, the development of novel technologies, wider adoption of telemedicine, and the introduction of innovative and effective medications.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21984&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Geographic Atrophy Industry?

The anticipated rise in age-related macular degeneration (AMD) cases is projected to drive expansion within the geographic atrophy market moving forward. Age-related macular degeneration, an ocular condition, primarily affects older individuals by harming the retina’s central region, thereby impairing their ability to discern intricate details. The increasing elderly demographic is a key factor contributing to AMD’s prevalence, given that extended lifespans and natural aging progressively damage the eyes, heightening susceptibility to the condition over time. Treatments for geographic atrophy assist AMD patients by decelerating the advancement of retinal damage and helping to maintain existing eyesight. For instance, in January 2024, a report by Medical News Today, a US-based digital media company, forecasted a global increase in age-related macular degeneration cases from 196 million to 288 million by 2040. Consequently, the growing incidence of age-related macular degeneration is fueling the expansion of the geographic atrophy market.

What Are The Leading Segments Analyzed In The Geographic Atrophy Market?

The geographic atrophymarket covered in this report is segmented –

1) By Drug Type: Anti-Vascular Endothelial Growth Factor (VEGF) Therapy; Complement Inhibitors; Neuroprotective Agents; Other Drugs

2) By Diagnosis: Fundus Autofluorescence (FAF); Optical Coherence Tomography Angiography (OCT-A); Multifocal Electroretinography (mfERG)

3) By Route Of Administration: Intravitreal; Oral; Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels

Subsegments:

1) By Anti-Vascular Endothelial Growth Factor (VEGF) Therapy: Ranibizumab; Aflibercept; Bevacizumab

2) By Complement Inhibitors: Pegcetacoplan; Lfg316

3) By Neuroprotective Agents: Latanoprost; Brimonidine

4) By Other Drugs: Steroids; Retinoids; Combination Therapy

What Are The Major Trends Driving The Growth Of The Geographic Atrophy Market?

Leading companies active in the geographic atrophy market are concentrating on innovative therapies, such as complement inhibitor therapy, to develop advanced treatments for geographic atrophy. Complement inhibitor therapy is a treatment designed to reduce an overactive immune response linked to certain diseases, thereby helping to safeguard healthy cells from damage and slow down disease progression. For instance, in February 2025, Astellas Pharma Inc., a Japan-based pharmaceutical company, announced that IZERVAY (avacincaptad pegol intravitreal solution) for geographic atrophy had been approved by the Food and Drug Administration, a US-based government agency. This approval permits the use of IZERVAY without a restriction on the duration of dosing for treating geographic atrophy (GA) secondary to age-related macular degeneration (AMD). This decision offers increased flexibility for managing GA, providing longer-term treatment options for both patients and healthcare providers.

Which Key Market Players Are Investing In Expansion And Innovation Of Geographic Atrophy Market?

Major companies operating in the geographic atrophy market are Regeneron Pharmaceuticals Inc., Boehringer Ingelheim, Astellas Pharma Inc., Biogen Inc., Ocugen Inc., Kodiak Sciences Inc., Apellis Pharmaceuticals Inc., NGM Biopharmaceuticals Inc., Voyager Therapeutics, Kriya Therapeutics, Stealth BioTherapeutics, Kiora Pharmaceuticals, Iveric Bio, Alkeus Pharmaceuticals, Nanoscope Therapeutics, Graybug Vision, SparingVision, 4D Molecular Therapeutics, Clearside Biomedical, Gensight Biologics

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/geographic-atrophy-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Geographic Atrophy Market?

North America was the largest region in the geographic atrophy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the geographic atrophy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Geographic Atrophy Market Report:

https://www.thebusinessresearchcompany.com/customise?id=21984&type=smp

Browse Through More Reports Similar to the Global Geographic Atrophy Market 2025, By The Business Research Company

Dry Eye Medication Market 2025

https://www.thebusinessresearchcompany.com/report/dry-eye-medication-market

Dry Eye Medication Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dry-eye-medication-global-market-report

Eyewear Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/eyewear-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795